ACCELERATOR
London, United Kingdom
London venture builder and pre-seed investor for UK science ventures improving the health of people or the planet. Makes an initial pre-seed investment of up to £250,000 and supports founders through their first two years. Pitch decks reviewed on a rolling basis.
Investment announcements in 2026 include KiloGen (15 Jun 2026), Neurolase (23 Jun 2026) and Nascent Therapeutics (3 Sep 2026).
Checked .
London
Early-stage investor running an eight-week, full-time residency in London where founders form teams and build. Backed companies get £210,000 at inception (£125,000 for 8.5% plus an £85,000 convertible note, with a £40,000 programme fee). It does not back solo founders.
London
Venture programmes for PhD researchers at UK and European universities. The part-time, nine-month Venture Scientist 100 fellowship and the 10-week Raise programme give top teams access to up to £300,000 in equity investment through XTX Ventures and a CX angel syndicate.
London
Talent investor that backs individuals before they have a co-founder or idea. Founders build in a full-time, in-person cohort in London and finish in San Francisco; EF invests up to $250,000 once a company is formed, with follow-on capital available.
Company Signal lists funders so founders can find them. We are not a broker or a financial adviser: we do not recommend funders, pass pitches on or take any fee from them, and nothing here is an offer of finance. Each entry comes from the funder's own public pages, last checked 1 Oct 2026; amounts, terms and rates change, so check them with the funder before you apply.